SEARCH

SEARCH BY CITATION

REFERENCES

  • Aguirre AJ,Brennan C,Bailey G,Sinha R,Feng B,Leo C,Zhang Y,Zhang J,Gans JD,Bardeesy N,Cauwels C,Cordon-Cardo C,Redston MS,DePinho RA,Chin L. 2004. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA 101: 90679072.
  • Aubry M,Monnier A,Chicault C,de Tayrac M,Galibert M-D,Burgun A,Mosser J. 2006. Combining evidence, biomedical literature and statistical dependence: New insights for functional annotation of gene sets. BMC Bioinformatics 7: 241.
  • Bagchi A,Papazoglu C,Wu Y,Capurso D,Brodt M,Francis D,Bredel M,Vogel H,Mills AA. 2007. CHD5 is a tumor suppressor at human 1p36. Cell 128: 459475.
  • Blum R,Jacob-Hirsch J,Rechavi G,Kloog Y. 2006. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. Mol Cancer Ther 5: 23372347.
  • Bredel M,Bredel C,Juric D,Harsh GR,Vogel H,Recht LD,Sikic BI. 2005a. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65: 86798689.
  • Bredel M,Bredel C,Juric D,Harsh GR,Vogel H,Recht LD,Sikic BI. 2005b. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 65: 40884096.
  • Chernova OB,Somerville RP,Cowell JK. 1998. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17: 28732881.
  • Ching Y-P,Wong C-M,Chan S-F,Leung TH-Y,Ng DC-H,Jin D-Y,Ng IO-l. 2003. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 278: 1082410830.
  • Daugaard M,Kirkegaard-Sørensen T,Ostenfeld MS,Aaboe M,Høyer-Hansen M,Orntoft TF,Rohde M,J\”a ataM. 2007. Lens epithelium-derived growth factor is an Hsp70–2 regulated guardian of lysosomal stability in human cancer. Cancer Res 67: 25592567.
  • Geiman TM,Sankpal UT,Robertson AK,Chen Y,Mazumdar M,Heale JT,Schmiesing JA,Kim W,Yokomori K,Zhao Y,Robertson KD. 2004. Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res 32: 27162729.
  • Hatch GM,Gu Y,Xu FY,Cizeau J,Neumann S,Park J-S,Loewen S,Mowat MRA. 2008. StARD13(Dlc-2) RhoGap mediates ceramide activation of phosphatidylglycerolphosphate synthase and drug response in Chinese hamster ovary cells. Mol Biol Cell 19: 10831092.
  • Hupé PH,Stransky N,Thiery J-P,ois Radvanyi Fc,Barillot E. 2004. Analysis of array CGH data: From signal ratio to gain and loss of DNA regions. Bioinformatics 20: 34133422.
  • Imoto I,Izumi H,Yokoi S,Hosoda H,Shibata T,Hosoda F,Ohki M,Hirohashi S,Inazawa J. 2006. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 66: 46174626.
  • Kirikoshi H,Katoh M. 2002. Expression and regulation of WNT10B in human cancer: Up-regulation of WNT10B in MCF-7 cells by beta-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 10: 507511.
  • Knobbe CB,Reifenberger G. 2003. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13: 507518.
  • Korones DN,Benita-Weiss M,Coyle TE,Mechtler L,Bushunow P,Evans B,Reardon DA,Quinn JA,Friedman H. 2003. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer 97: 19631968.
  • Kroes RA,Dawson G,Moskal JR. 2007. Focused microarray analysis of glyco-gene expression in human glioblastomas. J Neurochem 103 Suppl 1: 1424.
  • Liu F,Park PJ,Lai W,Maher E,Chakravarti A,Durso L,Jiang X,Yu Y,Brosius A,Thomas M,Chin L,Brennan C,DePinho RA,Kohane I,Carroll RS,Black PM,Johnson MD. 2006a. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res 66: 1081510823.
  • Liu G,Yuan X,Zeng Z,Tunici P,Ng H,Abdulkadir IR,Lu L,Irvin D,Black KL,Yu JS. 2006b. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67.
  • Maher EA,Brennan C,Wen PY,Durso L,Ligon KL,Richardson A,Khatry D,Feng B,Sinha R,Louis DN,Quackenbush J,Black PM,Chin L,DePinho RA. 2006. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 66: 1150211513.
  • Nagaraja GM,Kandpal RP. 2004. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem Biophys Res Commun 313: 654665.
  • Ng DC-H,Chan S-F,Kok KH,Yam JWP,Ching Y-P,Ng IO-L,Jin D-Y. 2006. Mitochondrial targeting of growth suppressor protein DLC2 through the START domain. FEBS Lett 580: 191198.
  • Nigro JM,Misra A,Zhang L,Smirnov I,Colman H,Griffin C,Ozburn N,Chen M,Pan E,Koul D,Yung WK,Feuerstein BG,Aldape KD. 2005. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65: 16781686.
  • Nutt CL,Mani DR,Betensky RA,Tamayo P,Cairncross JG,Ladd C,Pohl U,Hartmann C,McLaughlin ME,Batchelor TT,Black PM,von Deimling A,Pomeroy SL,Golub TR,Louis DN. 2003. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63: 16021607.
  • Okamoto OK,Oba-Shinjo SM,Lopes L,Marie SKN. 2007. Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes. Biochim Biophys Acta 1769: 437442.
  • Phillips HS,Kharbanda S,Chen R,Forrest WF,Soriano RH,Wu TD,Misra A,Nigro JM,Colman H,Soroceanu L,Williams PM,Modrusan Z,Feuerstein BG,Aldape K. 2006. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157173.
  • Raghavan R,Steart PV,Weller RO. 1990. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: A Ki-67 study. Neuropathol Appl Neurobiol 16: 123133.
  • Sarkar S,Nuttall RK,Liu S,Edwards DR,Yong VW. 2006. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res 66: 1177111780.
  • Schmid M,Sen M,Rosenbach MD,Carrera CJ,Friedman H,Carson DA. 2000. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene 19: 57475754.
  • Shou J,Ali-Osman F,Multani AS,Pathak S,Fedi P,Srivenugopal KS. 2002. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 21: 878889.
  • Smyth GK. 2005. Limma: Linear models for microarray data. In: GentlemanR, editor. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer, pp. 397420.
  • Soccio RE,Breslow JL. 2003. StAR-related lipid transfer (START) proteins: Mediators of intracellular lipid metabolism. J Biol Chem 278: 2218322186.
  • Solomon DA,Kim JS,Jenkins S,Ressom H,Huang M,Coppa N,Mabanta L,Bigner D,Yan H,Jean W,Waldman T. 2008. Identification of p18INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Res 68: 25642569.
  • Stupp R,Pica A,Mirimanoff RO,Michielin O. 2007. A practical guide for the management of gliomas. Bull Cancer 94: 817822.
  • Sun L,Hui A-M,Su Q,Vortmeyer A,Kotliarov Y,Pastorino S,Passaniti A,Menon J,Walling J,Bailey R,Rosenblum M,Mikkelsen T,Fine HA. 2006. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287300.
  • Tanwar MK,Gilbert MR,Holland EC. 2002. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62: 43644368.
  • Tso C-L,Freije WA,Day A,Chen Z,Merriman B,Perlina A,Lee Y,Dia EQ,Yoshimoto K,Mischel PS,Liau LM,Cloughesy TF,Nelson SF. 2006. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 66: 159167.
  • van den Boom J,Wolter M,Kuick R,Misek DE,Youkilis AS,Wechsler DS,Sommer C,Reifenberger G,Hanash SM. 2003. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163: 10331043.
  • Wang C-C,Liao Y-P,Mischel PS,Iwamoto KS,Cacalano NA,McBride WH. 2006. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Res 66: 67566762.
  • Wonsey DR,Follettie MT. 2005. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 65: 51815189.
  • Ylagan LR,Quinn B. 1997. CD44 expression in astrocytic tumors. Mod Pathol 10: 12391246.
  • Yuan BZ,Miller MJ,Keck CL,Zimonjic DB,Thorgeirsson SS,Popescu NC. 1998. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58: 21962199.